Print samachar

 Realme Q2 Pro Realme Q2 Pro smartphone runs on Android v10 (Q) operating system. The phone is powered by Octa core (2 GHz, Quad core, Cortex A76 + 2 GHz, Quad core, Cortex A55) processor. It runs on the MediaTek Dimensity 800 MT6873V Chipset. It has 8 GB, 8 GB RAM and 128 GB internal storage.Realme Q2 Pro smartphone has a AMOLED display. The screen has a resolution of 1080 x 2400 Pixels and 409 ppi pixel density. It has an aspect ratio of 20:9 and screen-to-body ratio of . On camera front, the buyers get a 64 MP Primary Camera, 8 MP, Wide Angle, Ultra-Wide Angle Camera, 2 MP, Macro Camera, 2 MP, Depth Camera and on the rear, there's an 64 MP + 8 MP + 2 MP + 2 MP camera with features like Digital Zoom, Auto Flash, Face detection, Touch to focus. It is backed by a 4200 mAh battery. Connectivity features in the smartphone include WiFi, Bluetooth, GPS, Volte, and more. Realme Q2 Pro Price in India Realme Q2 Pro smartphone price in India is likely to be Rs 21,999. Realme Q2 Pro is spec...

  A civil suit has been filed by 38 production houses and film bodies in Delhi HC against Republic TV and four journalists for their 'derogatory' remarks against Bollywood. As many as 34 top Bollywood producers and four film industry associations Monday filed a lawsuit in the Delhi High Court, seeking to restrain television channels from making “irresponsible, derogatory and defamatory remarks” against the Hindi film industry. The suit has been filed against Republic TV’s Editor-in-Chief Arnab Goswami and journalist Pradeep Bhandari of the channel, and Times Now’s Editor-in-Chief Rahul Shivshankar and its prominent anchor Navika Kumar as respondents. The production companies include those run by Salman Khan, Aamir Khan, Shah Rukh Khan, Karan Johar, Farhan Akhtar and Ajay Devgn. They have been assailed for conducting media trials of Bollywood personalities and interfering with the right to privacy of persons associated with the film industry, in the wake of Sushant Singh Rajput’...

Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections The Covid-19 vaccines closest to the finish line are designed to be injected into the arm. Researchers are looking at whether they can get better protection from inoculations that fight the virus at its point of attack - the nose and mouth. Most vaccines in human testing require two shots for effectiveness, and developers still aren't even sure if they'll prevent infections. Scientists are hoping to generate superior immune responses with inhaled vaccines that directly target the airway cells the virus invades. An alternative to conventional jabs, sprayed and inhaled immunizations under development in the U.S., Britain and Hong Kong could play an important role in helping society escape restrictions that have upended economies and everyday life. Among their goals is to prevent the pathogen from growing in the nose, a point from which it...